- Home
- APA vs ARWR Comparison
APA vs ARWR Comparison
Compare APA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APA | ARWR |
|---|---|---|
| Founded | 1954 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.0B |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | APA | ARWR |
|---|---|---|
| Price | $43.77 | $57.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 22 | 10 |
| Target Price | $29.82 | ★ $81.50 |
| AVG Volume (30 Days) | ★ 9.0M | 2.1M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.25% | N/A |
| EPS Growth | 75.77 | ★ 99.80 |
| EPS | ★ 3.99 | 0.22 |
| Revenue | N/A | ★ $16,142,321.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $11.14 | $262.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.58 | $10.66 |
| 52 Week High | $44.54 | $76.76 |
Technical Indicators
Market Signals| Indicator | APA | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 83.54 | 43.26 |
| Support Level | $22.73 | $54.02 |
| Resistance Level | N/A | $66.37 |
| Average True Range (ATR) | 1.49 | 2.99 |
| MACD | 0.69 | 0.31 |
| Stochastic Oscillator | 83.52 | 37.68 |
Price Performance
Historical ComparisonAbout APA APA Corporation
APA Corp is an independent exploration and production company. It develops, and produces crude oil, natural gas, and natural gas liquids. The Company's business has oil and gas operations in three geographic areas: the United States (U.S.), Egypt, and offshore the U.K. in the North Sea (North Sea). APA also has active development, exploration, and appraisal operations ongoing in Suriname, as well as exploration interests in Uruguay, Alaska, and other international locations.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.